Lilly, Novo, Pfizer look to new weight loss drugs

Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for weight-loss drugs. Even so, they’re already outlining their visions for the future of obesity drugs. At the American Diabetes Association’s Scientific Sessions in New Orleans last week, drugmakers pitched doctors and investors on the idea of new shots…

Read More

SpaceX COO Gwynne Shotwell has a message for investors

SpaceX didn’t just rewrite the playbook for aerospace and defense, it helped birth a new space economy. Now Elon Musk’s company is tackling a different type of moonshot: going public.  “I wasn’t sure we would go public,” SpaceX Chief Operating Officer Gwynne Shotwell told CNBC in an exclusive interview, just before the company started its…

Read More

FISA 702 lapse plunges US into unknown territory

The unprecedented repeal of the country’s warrant-less spying powers has left the country in legal uncertainty over the extent to which it can conduct surveillance on foreigners abroad. Amid outrage from Democrats, both houses of Congress on Thursday failed to pass a bill to extend Section 702 of the Foreign Intelligence Surveillance Act (FISA) until…

Read More